In the BioHarmony Drug Report Database
Retapamulin
Altabax (retapamulin) is a small molecule pharmaceutical. Retapamulin was first approved as Altabax on 2007-04-12. It is used to treat bacterial infections and impetigo in the USA. Altabax’s patents are valid until 2027-02-14 (FDA).
Trade Name
|
Altabax |
|---|---|
Common Name
|
retapamulin |
ChEMBL ID
|
CHEMBL1658 |
Indication
|
bacterial infections, impetigo |
Drug Class
|
Antibacterials, pleuromulin derivatives |
Image (chem structure or protein)